Vr Laboratories Selects Hsg2001 As Lead Development Candidate For Candida Albicans Program Company expanding into botanical medicine arena targeting fungal infection
Bonita Springs, Fla., Nov. 16, 2012 /PRNewswire-iReach/ -- VR Laboratories LLC today announced they have selected a lead product candidate based on preclinical activity to target Candida albicans (C. albicans). C. albicans is the most common yeast species that causes candidiasis, commonly referred to as yeast infections. Candidiasis includes topical infections such as thrush as well as systemic and potentially life-threatening invasive diseases.
Three of every four women experience at least one bout of candidiasis in their lifetime and many experience recurrent infections. Symptoms of candidiasis vary depending on the area of the body that is infected. Candidiasis can be severe and causes more fatalities than any other systemic fungal infection. Candida species are the most common cause of fungal infections in immunocompromised patients such as cancer, AIDS, and transplant patients.
HSG2001 is an orally administered and bioavailable product that prevents the growth of C. albicans in vitro. Preclinical data suggests the product could be used alone or in combination with known antifungals.
"We searched our industry leading natural product library and identified HSG2001 as our lead candidate based on its ability to inhibit C. albicans growth in early stage testing." said Jeff Kottkamp, CEO of VR Laboratories. "We are very excited to expand the utilization of our knowledge and proprietary technology into discovering potential natural medicines for diseases with high unmet medical needs."
About VR Laboratories
VR Laboratories is an innovative natural products company formed by industry professionals in 2010 to be the leading global formulator and producer of natural products. VR Laboratories utilizes industry-changing proprietary technology to create, produce and market "First in Class" condition specific botanical based consumer health and wellness products, FDA-approved botanical pharmaceuticals and medicines, and proprietary ingredients for medicinal and functional foods and beverages. The company utilizes a proprietary technology platform created by HerbalScience, which has fully developed more than 1,000 medicinal and functional ingredients. VR Laboratories is headquartered in Bonita Springs, Florida.
SOURCE VR Laboratories www.vr-laboratories.com
Key Words: VR laboratories, Jeff Kottkamp, botanical, c. albicans, medicines, pharmaceuticals, natural, yeast infection
SOURCE VR Laboratories LLC